|
BioIVT Inc
diseased ipf lung fibroblasts ![]() Diseased Ipf Lung Fibroblasts, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/diseased+ipf+lung+fibroblasts/pmc11272128-159-13-20?v=BioIVT+Inc Average 90 stars, based on 1 article reviews
diseased ipf lung fibroblasts - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Lonza
cryopreserved ampules of diseased human lung fibroblasts, idiopathic pulmonary fibrosis (dhlf-ipf) ![]() Cryopreserved Ampules Of Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis (Dhlf Ipf), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/diseased+ipf+lung+fibroblasts/pmc09103910-123-1-21?v=Lonza Average 90 stars, based on 1 article reviews
cryopreserved ampules of diseased human lung fibroblasts, idiopathic pulmonary fibrosis (dhlf-ipf) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Cryopreserved ampule of Diseased Human Lung Fibroblasts, Idiopathic Pulmonary Fibrosis (DHLF-IPF) containing ≥ 500,000 cells
|
Buy from Supplier |
Image Search Results
Journal: Aging (Albany NY)
Article Title: Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells
doi: 10.18632/aging.205994
Figure Lengend Snippet: DNA damage is a hallmark of commercial primary IPF fibroblasts in vitro , but not Cdkn2a /p16 ink4a expression or a fibrotic secretome . ( A ) Primary NHLF and IPF cells ( n = 3 different donors, each with 2 technical replicates) were cultured at the same density overnight on standard tissue culture plates in low-serum growth medium and were subsequently fixed. Immunocytochemistry was performed to fluorescently label nuclei (blue) and p21 Waf1/Cip1 (orange). Images were acquired with a 40X water objective using an Operetta High Content Screening instrument and intensity of nuclear p21 Waf1/Cip1 was quantified and calculated as a positive percentage of each population. ( B ) NHLF and IPF cells were treated and imaged as in ( A ), and immunocytochemistry was performed to fluorescently label nuclei (blue) and DNA damage via nuclear γH2A.X (Ser139) foci (orange). The number of nuclear foci per cell was quantified and cells with one or more were reported as positive. ( C ) Following overnight culture in standard tissue culture plates, NHLF and IPF cells were lysed, and qPCR was performed. Expression of senescence and fibrosis-related matrix and secreted factor genes was assessed, and data were normalized to β2m housekeeper expression using the 2 −ΔΔCt method versus NHLF cells. ( D ) Following overnight culture as in ( C ), cell culture supernatants were collected and assayed for determination of the concentration of common fibrosis-related secreted proteins by MSD kits. Statistical analysis was performed using an unpaired t -test ( A , B ) or a two-way ANOVA with a Bonferroni post-test ( C , D ) in GraphPad Prism: * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars represent standard error of the mean (SEM).
Article Snippet: Primary normal human lung fibroblasts (NHLF) were purchased from Lonza and ATCC, and
Techniques: In Vitro, Expressing, Cell Culture, Immunocytochemistry, High Content Screening, Concentration Assay
Journal: Aging (Albany NY)
Article Title: Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells
doi: 10.18632/aging.205994
Figure Lengend Snippet: Summary of in vitro and ex vivo systems to mimic alveolar epithelial and fibroblast damage and dysfunction in the IPF lung. While IPF fibroblasts and bleomycin treated NHLFs exhibit some hallmarks of senescence, these cells do not appear to demonstrate a phenotype of Cdkn2a /p16 ink4a expression, ECM deposition, or secretion of fibrotic mediators such as TIMP1. Rather, the SASP of senescent, aberrant epithelial cells drives a fibrotic phenotype in NHLFs that is consistent with progressive fibrosis. Development of senolytic agents presents an opportunity for therapeutic impact early in disease pathogenesis and with an orthogonal mechanism than the fibroblast targeting standard of care, Nintedanib. Image created with https://www.biorender.com/ .
Article Snippet: Primary normal human lung fibroblasts (NHLF) were purchased from Lonza and ATCC, and
Techniques: In Vitro, Ex Vivo, Expressing